AComprehensive approach to multimodal facial aesthetic treatment

Injection techniques and treatment characteristics from the HARMONY study

Vic A. Narurkar, Joel L. Cohen, Steven Dayan, Michael S. Kaminer, Alexander Rivkin, Ava Shamban, Jonathan M Sykes, Craig F. Teller, Susan H. Weinkle, W. Philip Werschler, Adrienne Drinkwater, Michael L. Pucci, Conor J. Gallagher

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background The Harmony study is the first clinical trial to assess the impact of a global approach to facial rejuvenation with several minimally invasive modalities, using patient-reported outcome measures. OBJECTIVE Provide details of this treatment approach and describe investigators' experiences and recommendations based on this study. METHODS This multicenter, 4-month study evaluated subject satisfaction with and psychological impact of combined treatment with VYC-20L (Juv éderm Voluma XC), HYC-24L (Juv éderm Ultra XC), HYC-24L+ (Juv éderm Ultra Plus XC), onabotulinumtoxinA (Botox), and bimatoprost 0.3% ophthalmic solution (Latisse). Treatment-naive adults with moderate-to-severe facial lines and folds and eyelash hypotrichosis received onlabel, staged treatment with fillers. Bimatoprost was self-administered once daily for 17 weeks from day 1. OnabotulinumtoxinA was administered for glabellar lines, crow's feet lines, or both at month 3. RESULTS Overall, 100 subjects received bimatoprost for eyelash hypotrichosis, 96 received onabotulinumtoxinA for glabellar lines and/or crow's feet lines, and 96 received VYC-20L for midface volume deficit. From 17 to 96 subjects received HYC-24L and/or HYC-24L+ for nasolabial folds, oral commissures, marionette lines, perioral lines, or radial cheek lines. Injections of filler generally progressed from cranial to caudal, with midface injected first. Investigator-reported factors that may have contributed to the potential benefits of this approach include the critical role of themidface in facial aesthetics, use of lower volumes of filler in individual facial areas, and anesthetic effects. CONCLUSION The investigators' perspectives and experience with the injection pattern, sequencing, volumes, and techniques may provide valuable guidance for a multimodal approach to facial aesthetic treatment.

Original languageEnglish (US)
Pages (from-to)S177-S191
JournalDermatologic Surgery
Volume42
DOIs
StatePublished - May 15 2016

Fingerprint

Esthetics
Hypotrichosis
Injections
Eyelashes
Crows
Research Personnel
Foot
Nasolabial Fold
Rejuvenation
Therapeutics
Ophthalmic Solutions
Cheek
Anesthetics
Clinical Trials
Psychology
onabotulinumtoxinA
Bimatoprost

ASJC Scopus subject areas

  • Dermatology
  • Surgery

Cite this

AComprehensive approach to multimodal facial aesthetic treatment : Injection techniques and treatment characteristics from the HARMONY study. / Narurkar, Vic A.; Cohen, Joel L.; Dayan, Steven; Kaminer, Michael S.; Rivkin, Alexander; Shamban, Ava; Sykes, Jonathan M; Teller, Craig F.; Weinkle, Susan H.; Philip Werschler, W.; Drinkwater, Adrienne; Pucci, Michael L.; Gallagher, Conor J.

In: Dermatologic Surgery, Vol. 42, 15.05.2016, p. S177-S191.

Research output: Contribution to journalArticle

Narurkar, VA, Cohen, JL, Dayan, S, Kaminer, MS, Rivkin, A, Shamban, A, Sykes, JM, Teller, CF, Weinkle, SH, Philip Werschler, W, Drinkwater, A, Pucci, ML & Gallagher, CJ 2016, 'AComprehensive approach to multimodal facial aesthetic treatment: Injection techniques and treatment characteristics from the HARMONY study', Dermatologic Surgery, vol. 42, pp. S177-S191. https://doi.org/10.1097/DSS.0000000000000743
Narurkar, Vic A. ; Cohen, Joel L. ; Dayan, Steven ; Kaminer, Michael S. ; Rivkin, Alexander ; Shamban, Ava ; Sykes, Jonathan M ; Teller, Craig F. ; Weinkle, Susan H. ; Philip Werschler, W. ; Drinkwater, Adrienne ; Pucci, Michael L. ; Gallagher, Conor J. / AComprehensive approach to multimodal facial aesthetic treatment : Injection techniques and treatment characteristics from the HARMONY study. In: Dermatologic Surgery. 2016 ; Vol. 42. pp. S177-S191.
@article{13eaa89023744be38fe166f1d4dbf492,
title = "AComprehensive approach to multimodal facial aesthetic treatment: Injection techniques and treatment characteristics from the HARMONY study",
abstract = "Background The Harmony study is the first clinical trial to assess the impact of a global approach to facial rejuvenation with several minimally invasive modalities, using patient-reported outcome measures. OBJECTIVE Provide details of this treatment approach and describe investigators' experiences and recommendations based on this study. METHODS This multicenter, 4-month study evaluated subject satisfaction with and psychological impact of combined treatment with VYC-20L (Juv {\'e}derm Voluma XC), HYC-24L (Juv {\'e}derm Ultra XC), HYC-24L+ (Juv {\'e}derm Ultra Plus XC), onabotulinumtoxinA (Botox), and bimatoprost 0.3{\%} ophthalmic solution (Latisse). Treatment-naive adults with moderate-to-severe facial lines and folds and eyelash hypotrichosis received onlabel, staged treatment with fillers. Bimatoprost was self-administered once daily for 17 weeks from day 1. OnabotulinumtoxinA was administered for glabellar lines, crow's feet lines, or both at month 3. RESULTS Overall, 100 subjects received bimatoprost for eyelash hypotrichosis, 96 received onabotulinumtoxinA for glabellar lines and/or crow's feet lines, and 96 received VYC-20L for midface volume deficit. From 17 to 96 subjects received HYC-24L and/or HYC-24L+ for nasolabial folds, oral commissures, marionette lines, perioral lines, or radial cheek lines. Injections of filler generally progressed from cranial to caudal, with midface injected first. Investigator-reported factors that may have contributed to the potential benefits of this approach include the critical role of themidface in facial aesthetics, use of lower volumes of filler in individual facial areas, and anesthetic effects. CONCLUSION The investigators' perspectives and experience with the injection pattern, sequencing, volumes, and techniques may provide valuable guidance for a multimodal approach to facial aesthetic treatment.",
author = "Narurkar, {Vic A.} and Cohen, {Joel L.} and Steven Dayan and Kaminer, {Michael S.} and Alexander Rivkin and Ava Shamban and Sykes, {Jonathan M} and Teller, {Craig F.} and Weinkle, {Susan H.} and {Philip Werschler}, W. and Adrienne Drinkwater and Pucci, {Michael L.} and Gallagher, {Conor J.}",
year = "2016",
month = "5",
day = "15",
doi = "10.1097/DSS.0000000000000743",
language = "English (US)",
volume = "42",
pages = "S177--S191",
journal = "Dermatologic Surgery",
issn = "1076-0512",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - AComprehensive approach to multimodal facial aesthetic treatment

T2 - Injection techniques and treatment characteristics from the HARMONY study

AU - Narurkar, Vic A.

AU - Cohen, Joel L.

AU - Dayan, Steven

AU - Kaminer, Michael S.

AU - Rivkin, Alexander

AU - Shamban, Ava

AU - Sykes, Jonathan M

AU - Teller, Craig F.

AU - Weinkle, Susan H.

AU - Philip Werschler, W.

AU - Drinkwater, Adrienne

AU - Pucci, Michael L.

AU - Gallagher, Conor J.

PY - 2016/5/15

Y1 - 2016/5/15

N2 - Background The Harmony study is the first clinical trial to assess the impact of a global approach to facial rejuvenation with several minimally invasive modalities, using patient-reported outcome measures. OBJECTIVE Provide details of this treatment approach and describe investigators' experiences and recommendations based on this study. METHODS This multicenter, 4-month study evaluated subject satisfaction with and psychological impact of combined treatment with VYC-20L (Juv éderm Voluma XC), HYC-24L (Juv éderm Ultra XC), HYC-24L+ (Juv éderm Ultra Plus XC), onabotulinumtoxinA (Botox), and bimatoprost 0.3% ophthalmic solution (Latisse). Treatment-naive adults with moderate-to-severe facial lines and folds and eyelash hypotrichosis received onlabel, staged treatment with fillers. Bimatoprost was self-administered once daily for 17 weeks from day 1. OnabotulinumtoxinA was administered for glabellar lines, crow's feet lines, or both at month 3. RESULTS Overall, 100 subjects received bimatoprost for eyelash hypotrichosis, 96 received onabotulinumtoxinA for glabellar lines and/or crow's feet lines, and 96 received VYC-20L for midface volume deficit. From 17 to 96 subjects received HYC-24L and/or HYC-24L+ for nasolabial folds, oral commissures, marionette lines, perioral lines, or radial cheek lines. Injections of filler generally progressed from cranial to caudal, with midface injected first. Investigator-reported factors that may have contributed to the potential benefits of this approach include the critical role of themidface in facial aesthetics, use of lower volumes of filler in individual facial areas, and anesthetic effects. CONCLUSION The investigators' perspectives and experience with the injection pattern, sequencing, volumes, and techniques may provide valuable guidance for a multimodal approach to facial aesthetic treatment.

AB - Background The Harmony study is the first clinical trial to assess the impact of a global approach to facial rejuvenation with several minimally invasive modalities, using patient-reported outcome measures. OBJECTIVE Provide details of this treatment approach and describe investigators' experiences and recommendations based on this study. METHODS This multicenter, 4-month study evaluated subject satisfaction with and psychological impact of combined treatment with VYC-20L (Juv éderm Voluma XC), HYC-24L (Juv éderm Ultra XC), HYC-24L+ (Juv éderm Ultra Plus XC), onabotulinumtoxinA (Botox), and bimatoprost 0.3% ophthalmic solution (Latisse). Treatment-naive adults with moderate-to-severe facial lines and folds and eyelash hypotrichosis received onlabel, staged treatment with fillers. Bimatoprost was self-administered once daily for 17 weeks from day 1. OnabotulinumtoxinA was administered for glabellar lines, crow's feet lines, or both at month 3. RESULTS Overall, 100 subjects received bimatoprost for eyelash hypotrichosis, 96 received onabotulinumtoxinA for glabellar lines and/or crow's feet lines, and 96 received VYC-20L for midface volume deficit. From 17 to 96 subjects received HYC-24L and/or HYC-24L+ for nasolabial folds, oral commissures, marionette lines, perioral lines, or radial cheek lines. Injections of filler generally progressed from cranial to caudal, with midface injected first. Investigator-reported factors that may have contributed to the potential benefits of this approach include the critical role of themidface in facial aesthetics, use of lower volumes of filler in individual facial areas, and anesthetic effects. CONCLUSION The investigators' perspectives and experience with the injection pattern, sequencing, volumes, and techniques may provide valuable guidance for a multimodal approach to facial aesthetic treatment.

UR - http://www.scopus.com/inward/record.url?scp=84969509089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969509089&partnerID=8YFLogxK

U2 - 10.1097/DSS.0000000000000743

DO - 10.1097/DSS.0000000000000743

M3 - Article

VL - 42

SP - S177-S191

JO - Dermatologic Surgery

JF - Dermatologic Surgery

SN - 1076-0512

ER -